spiro compound, the pharmaceutically acceptable salt thereof or the solvate thereof, pharmaceutical composition, gpr40 agonist medicament, insulin secretion promoting agent or a hypoglycemic agent, use of the spiro compound, the pharmaceutically acceptable salt thereof or the solvate thereof, and methods for gpr40 activation, to promote insulin secretion or to lower blood glucose level, and to treat or prevent a disease.

• 收藏
• 分享

专利权人:

Japan Tobacco Inc.

发明人:

Hiroshi Ueno,Kasuhiro Tsutsumi,Kouchi Aoyagi,Shin-ya Sasaki,Susumo Katoh,Takashi Shimada,Tomoyuki Manabe

申请号：

BRPI0818687

公开号：

BRPI0818687A2

申请日:

2008.10.24

申请国别(地区):

BR

年份:

2017

代理人:

摘要：

The spiro compound represented by the following general formula [Ia], its pharmaceutically acceptable salt or a solvate thereof

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/